Compounds > valine

valine and ristocetin

valine has been researched along with ristocetin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murata, M; Ruggeri, ZM; Russell, SR; Ware, J1
Anbo, H; Handa, M; Ikeda, Y; Kitaguchi, T; Moriki, T; Murata, M; Takahashi, H; Watanabe, K1
Canciani, MT; Di Rocco, N; Federici, AB; Mannucci, PM; Miyata, S; Ruggeri, ZM; Stabile, F; Ware, J1
Andrews, RK; Dong, J; Gao, S; López, JA; McIntire, LV; Romo, GM; Schade, AJ1
Berndt, MC; Cruz, MA; López, JA; Peng, Y1

Other Studies

5 other study(ies) available for valine and ristocetin

ArticleYear
Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment.
    The Journal of clinical investigation, 1993, Volume: 91, Issue:5

    Topics: Amino Acid Sequence; Animals; Blood Platelets; CHO Cells; Cricetinae; Crotalid Venoms; Genetic Variation; Glycine; Hemagglutinins; Humans; Kinetics; Macromolecular Substances; Phenotype; Platelet Membrane Glycoproteins; Recombinant Proteins; Ristocetin; Transfection; Valine; von Willebrand Diseases; von Willebrand Factor

1993
Expression and functional characterization of an abnormal platelet membrane glycoprotein Ib alpha (Met239 --> Val) reported in patients with platelet-type von Willebrand disease.
    Blood, 1997, Jul-15, Volume: 90, Issue:2

    Topics: Analysis of Variance; Humans; Methionine; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Point Mutation; Recombinant Proteins; Ristocetin; Transfection; Valine; von Willebrand Diseases

1997
A type 2b von Willebrand disease mutation (Ile546-->Val) associated with an unusual phenotype.
    Thrombosis and haemostasis, 1997, Volume: 78, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Child; Female; Humans; Isoleucine; Male; Middle Aged; Phenotype; Platelet Aggregation; Point Mutation; Restriction Mapping; Ristocetin; Sequence Analysis, DNA; Valine; von Willebrand Diseases; von Willebrand Factor

1997
Novel gain-of-function mutations of platelet glycoprotein IBalpha by valine mutagenesis in the Cys209-Cys248 disulfide loop. Functional analysis under statis and dynamic conditions.
    The Journal of biological chemistry, 2000, Sep-08, Volume: 275, Issue:36

    Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; CHO Cells; Cricetinae; Crotalid Venoms; Cysteine; Disulfides; Hemagglutinins; Humans; Kinetics; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Platelet Glycoprotein GPIb-IX Complex; Protein Structure, Secondary; Recombinant Proteins; Ristocetin; Transfection; Valine; von Willebrand Factor

2000
The alpha1 helix-beta13 strand spanning Leu214 to Val229 of platelet glycoprotein Ibalpha facilitates the interaction with von Willebrand factor: evidence from characterization of the epitope of monoclonal antibody AP1.
    Blood, 2004, Dec-15, Volume: 104, Issue:13

    Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Antibodies, Monoclonal; Binding Sites; CHO Cells; Cricetinae; Crotalid Venoms; Epitopes; Humans; Leucine; Membrane Glycoproteins; Membrane Proteins; Molecular Sequence Data; Mutagenesis, Site-Directed; Platelet Glycoprotein GPIb-IX Complex; Protein Binding; Protein Structure, Secondary; Recombinant Proteins; Ristocetin; Transcription Factor AP-1; Valine; von Willebrand Factor

2004